Groupe la Francaise Takes Position in Cigna Group $CI

Groupe la Francaise acquired a new position in Cigna Group (NYSE:CI) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 16,171 shares of the health services provider’s stock, valued at approximately $5,322,000.

Other large investors have also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC acquired a new position in Cigna Group during the 1st quarter worth $28,000. 1248 Management LLC acquired a new stake in Cigna Group in the first quarter worth about $29,000. Solstein Capital LLC acquired a new stake in Cigna Group in the second quarter worth about $29,000. Chilton Capital Management LLC bought a new position in Cigna Group in the 2nd quarter valued at about $30,000. Finally, Activest Wealth Management increased its stake in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after buying an additional 72 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Price Performance

CI opened at $270.45 on Thursday. The stock has a fifty day moving average of $283.95 and a 200-day moving average of $296.51. The firm has a market capitalization of $72.24 billion, a P/E ratio of 11.93, a PEG ratio of 0.99 and a beta of 0.26. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.Cigna Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

Insider Activity at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the purchase, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of several recent analyst reports. Zacks Research cut shares of Cigna Group from a “hold” rating to a “strong sell” rating in a report on Monday, November 3rd. JPMorgan Chase & Co. cut their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. Wolfe Research lowered their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. UBS Group set a $294.00 price objective on Cigna Group in a research note on Wednesday, November 12th. Finally, Cantor Fitzgerald cut their price objective on Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $334.45.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.